Acute, Subclinical, and Subacute Mastitis

2016 ◽  
Vol 7 (1) ◽  
pp. 7-10 ◽  
Author(s):  
Carmela Baeza
Keyword(s):  
Clinical Management ◽  
Clinical Settings ◽  
Evidence Based ◽  
Breast Pain ◽  
Management Guidelines ◽  
Acute Mastitis

There is a controversy about the origin, definition, and types of acute mastitis, breast pain, and their clinical management. This article reviews current definitions, bacteriological findings, their possible meanings, and their use in clinical settings as well as the latest evidence-based clinical management guidelines.

Deviations from evidence-based clinical management guidelines increase mortality in critically injured trauma patients*

2012 ◽  
Vol 40 (3) ◽  
pp. 778-786 ◽  
Author(s):  
Todd W. Rice ◽  
Stephen Morris ◽  
Bartholomew J. Tortella ◽  
Arthur P. Wheeler ◽  
Michael C. Christensen
Keyword(s):  
Clinical Management ◽  
Evidence Based ◽  
Trauma Patients ◽  
Management Guidelines

scholarly journals Compliance with evidence-based clinical management guidelines in bleeding trauma patients

2016 ◽  
Vol 117 (5) ◽  
pp. 592-600 ◽  
Author(s):  
A. Godier ◽  
M. Bacus ◽  
E. Kipnis ◽  
B. Tavernier ◽  
A. Guidat ◽  
...  
Keyword(s):  
Clinical Management ◽  
Evidence Based ◽  
Trauma Patients ◽  
Management Guidelines

Chronic Mastitis, Mastalgia, and Breast Pain

2016 ◽  
Vol 7 (1) ◽  
pp. 11-17
Author(s):  
Carmela Baeza
Keyword(s):  
Clinical Experience ◽  
Scientific Evidence ◽  
Clinical Settings ◽  
Breast Pain ◽  
Microbiological Techniques ◽  
Acute Mastitis

Whereas the management of acute mastitis seems clear, there is little scientific evidence to support management of chronic mastitis/breast pain. This article reviews bacteriological findings, their possible meanings, and their use in clinical settings. Clinical experience, newer and more accurate microbiological techniques, and the growing knowledge about our metagenome have many insights to offer.

Strategies to improve compliance with evidence-based clinical management guidelines

1999 ◽  
Vol 189 (6) ◽  
pp. 533-538 ◽  
Author(s):  
Heidi L Frankel ◽  
Mary Kate FitzPatrick ◽  
Sharon Gaskell ◽  
William S Hoff ◽  
Michael F Rotondo ◽  
...  
Keyword(s):  
Clinical Management ◽  
Evidence Based ◽  
Management Guidelines ◽  
Improve Compliance

scholarly journals Accessibility, inclusivity, and implementation of COVID-19 clinical management guidelines early in the pandemic: a global survey

2021 ◽  
Author(s):  
Caitlin Pilbeam ◽  
Deborah Malden ◽  
Katherine Newell ◽  
Andrew Dagens ◽  
Kalynn Kennon ◽  
...  
Keyword(s):  
At Risk ◽  
Supportive Care ◽  
Clinical Management ◽  
Rapid Review ◽  
Evidence Based ◽  
Science Literature ◽  
Management Guidelines ◽  
At Risk Populations ◽  
Evidence Based Care ◽  
Improve Access

AbstractBackgroundWith a rapidly changing evidence base, high-quality clinical management guidelines (CMGs) are key tools for aiding clinical decision making and increasing access to best available evidence-based care. A rapid review of COVID-19 CMGs found that most lacked methodological rigour, overlooked many at-risk populations, and had variations in treatment recommendations. Furthermore, social science literature highlights the complexity of implementing guidelines in local contexts where they were not developed and the resulting potential to compound health inequities. The aim of this study was to evaluate access to, inclusivity of, and implementation of Covid-19 CMGs in different settings.MethodsA cross-sectional survey of clinicians worldwide from 15 June to 20 July 2020, to explore access to and implementation of Covid-19 CMGs and treatment and supportive care recommendations provided. Data on accessibility, inclusivity, and implementation of CMGs. were analyzed by geographic location.ResultsSeventy-six clinicians, from 27 countries responded, 82% from high-income countries, 17% from low-middle income countries. Most respondents reported access to Covid-19 CMG and confidence in implementation of these. However, many respondents, particularly from LMICs reported barriers to implementation, including limited access to treatments and equipment. Only 20% of respondents reported having access to CMGs covering care for children, 25% for pregnant women and 50% for older adults (>65 years). Themes emerging were for CMGs to include recommendations for different at-risk populations, and settings, include supportive care guidance, be readily updated as evidence emerges, and CMG implementation supported by training, and access to treatments recommended.ConclusionOur findings highlight important gaps in Covid-19 CMG development and implementation challenges during a pandemic, particularly affecting different at-risk populations and lower resourced settings., to improve access in evidence-based care recommendations during an emergency. The findings identifies an urgent need for an improved framework for CMG development, that is inclusive and adaptable to emerging evidence and considers contextual implementation support, to improve access to evidence-based care globally.

Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation

2018 ◽  
Vol 32 (6) ◽  
pp. 601-640 ◽  
Author(s):  
Maxine X Patel ◽  
Faisil N Sethi ◽  
Thomas RE Barnes ◽  
Roland Dix ◽  
Luiz Dratcu ◽  
...  
Keyword(s):  
Clinical Management ◽  
Clinical Settings ◽  
Evidence Based ◽  
Pharmacological Interventions ◽  
Adult Inpatient ◽  
Medical Emergencies ◽  
Acute Disturbance ◽  
Trained Staff ◽  
Underlying Disorder ◽  
Key Interventions

The British Association for Psychopharmacology and the National Association of Psychiatric Intensive Care and Low Secure Units developed this joint evidence-based consensus guideline for the clinical management of acute disturbance. It includes recommendations for clinical practice and an algorithm to guide treatment by healthcare professionals with various options outlined according to their route of administration and category of evidence. Fundamental overarching principles are included and highlight the importance of treating the underlying disorder. There is a focus on three key interventions: de-escalation, pharmacological interventions pre-rapid tranquillisation and rapid tranquillisation (intramuscular and intravenous). Most of the evidence reviewed relates to emergency psychiatric care or acute psychiatric adult inpatient care, although we also sought evidence relevant to other common clinical settings including the general acute hospital and forensic psychiatry. We conclude that the variety of options available for the management of acute disturbance goes beyond the standard choices of lorazepam, haloperidol and promethazine and includes oral-inhaled loxapine, buccal midazolam, as well as a number of oral antipsychotics in addition to parenteral options of intramuscular aripiprazole, intramuscular droperidol and intramuscular olanzapine. Intravenous options, for settings where resuscitation equipment and trained staff are available to manage medical emergencies, are also included.

scholarly journals Accessibility, inclusivity, and implementation of COVID-19 clinical management guidelines early in the pandemic: a global survey

2021 ◽  
Vol 6 ◽  
pp. 247
Author(s):  
Caitlin Pilbeam ◽  
Deborah Malden ◽  
Katherine Newell ◽  
Andrew Dagens ◽  
Kalynn Kennon ◽  
...  
Keyword(s):  
At Risk ◽  
Supportive Care ◽  
Clinical Management ◽  
Rapid Review ◽  
Evidence Based ◽  
Science Literature ◽  
Management Guidelines ◽  
Development Framework ◽  
At Risk Populations ◽  
Evidence Based Care

Background: With a rapidly changing evidence base, high-quality clinical management guidelines (CMGs) are key tools for aiding clinical decision making and increasing access to best available evidence-based care. A rapid review of COVID-19 CMGs found most lacked methodological rigour, overlooked at-risk populations, and varied in treatment recommendations. Furthermore, social science literature highlights the complexity of implementing guidelines in local contexts where they were not developed and the resulting potential to compound health inequities. This study aimed to evaluate access to, inclusivity of, and implementation of COVID-19 CMGs in different settings. Methods: A cross-sectional survey of clinicians worldwide was conducted from 15th June to 20th July 2020, to explore access to and implementation of COVID-19 CMGs, and treatment and supportive care recommendations provided. Data on accessibility, inclusivity, and implementation of CMGs were analysed by geographic location. Results: 76 clinicians from 27 countries responded: 82% from high-income countries, 17% from lower middle-income countries (LMICs). Most respondents reported access to COVID-19 CMGs and confidence in their implementation. However, many respondents, particularly from LMICs, reported barriers to implementation, including limited access to treatment and equipment. Only 20% of respondents reported having access to CMGs covering care for children, 25% for pregnant women, and 50% for older adults (>65 years). Identified themes were for CMGs to include recommendations for at-risk populations and settings, include supportive care guidance, and be updated as evidence emerges, and for clinicians to have training and access to recommended treatments to support implementation. Conclusion: Our findings highlight important gaps in COVID-19 CMG development and implementation challenges during a pandemic, particularly affecting at-risk populations and lower resourced settings. This study identifies an urgent need for an improved CMG development framework that is inclusive and adaptable to emerging evidence and considers contextual implementation support, to improve access to evidence-based care globally.

scholarly journals Saudi Oncology Society clinical management guidelines for testicular germ cell tumors

2011 ◽  
Vol 3 (4) ◽  
pp. 17
Author(s):  
Mohammed Al Otaibi ◽  
Mohammed El-naghi ◽  
Khaled Balaraj ◽  
Shouki Bazarbashi ◽  
Dany Rabbah ◽  
...  
Keyword(s):  
Germ Cell ◽  
Clinical Management ◽  
Germ Cell Tumors ◽  
Testicular Germ Cell Tumors ◽  
Testicular Germ Cell ◽  
Management Guidelines
Sign in / Sign up

Export Citation Format

Share Document